These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12444168)

  • 1. Antigen-based immunotherapy drives the precocious development of autoimmunity.
    Tian J; Olcott AP; Kaufman DL
    J Immunol; 2002 Dec; 169(11):6564-9. PubMed ID: 12444168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-based therapies using ignored determinants of beta cell antigens can more effectively inhibit late-stage autoimmune disease in diabetes-prone mice.
    Olcott AP; Tian J; Walker V; Dang H; Middleton B; Adorini L; Washburn L; Kaufman DL
    J Immunol; 2005 Aug; 175(3):1991-9. PubMed ID: 16034144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.
    Tian J; Atkinson MA; Clare-Salzler M; Herschenfeld A; Forsthuber T; Lehmann PV; Kaufman DL
    J Exp Med; 1996 Apr; 183(4):1561-7. PubMed ID: 8666914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of inducible Th2 immunity with autoimmune disease progression.
    Tian J; Kaufman DL
    J Immunol; 1998 Nov; 161(10):5399-403. PubMed ID: 9820514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens.
    Tian J; Lehmann PV; Kaufman DL
    J Exp Med; 1997 Dec; 186(12):2039-43. PubMed ID: 9396773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent.
    Tisch R; Wang B; Serreze DV
    J Immunol; 1999 Aug; 163(3):1178-87. PubMed ID: 10415012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.
    Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L
    J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cells are crucial for determinant spreading of T cell autoimmunity among beta cell antigens in diabetes-prone nonobese diabetic mice.
    Tian J; Zekzer D; Lu Y; Dang H; Kaufman DL
    J Immunol; 2006 Feb; 176(4):2654-61. PubMed ID: 16456028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infectious Th1 and Th2 autoimmunity in diabetes-prone mice.
    Tian J; Olcott AP; Hanssen LR; Zekzer D; Middleton B; Kaufman DL
    Immunol Rev; 1998 Aug; 164():119-27. PubMed ID: 9795770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenically induced GAD tolerance curtails the development of early beta-cell autoreactivities but causes the subsequent development of supernormal autoreactivities to other beta-cell antigens.
    Tian J; Dang H; von Boehmer H; Jaeckel E; Kaufman DL
    Diabetes; 2009 Dec; 58(12):2843-50. PubMed ID: 19741165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells.
    Yoon JW; Yoon CS; Lim HW; Huang QQ; Kang Y; Pyun KH; Hirasawa K; Sherwin RS; Jun HS
    Science; 1999 May; 284(5417):1183-7. PubMed ID: 10325232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The frequency of high avidity T cells determines the hierarchy of determinant spreading.
    Tian J; Gregori S; Adorini L; Kaufman DL
    J Immunol; 2001 Jun; 166(12):7144-50. PubMed ID: 11390460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active tolerance induction and prevention of autoimmune diabetes by immunogene therapy using recombinant adenoassociated virus expressing glutamic acid decarboxylase 65 peptide GAD(500-585).
    Han G; Li Y; Wang J; Wang R; Chen G; Song L; Xu R; Yu M; Wu X; Qian J; Shen B
    J Immunol; 2005 Apr; 174(8):4516-24. PubMed ID: 15814672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice.
    Tisch R; Wang B; Atkinson MA; Serreze DV; Friedline R
    J Immunol; 2001 Jun; 166(11):6925-36. PubMed ID: 11359854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen.
    Laloux V; Beaudoin L; Jeske D; Carnaud C; Lehuen A
    J Immunol; 2001 Mar; 166(6):3749-56. PubMed ID: 11238616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccination encoding glutamic acid decarboxylase can enhance insulitis and diabetes in correlation with a specific Th2/3 CD4 T cell response in non-obese diabetic mice.
    Gauvrit A; Debailleul M; Vu AT; Sai P; Bach JM
    Clin Exp Immunol; 2004 Aug; 137(2):253-62. PubMed ID: 15270841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.
    Tian J; Zekzer D; Hanssen L; Lu Y; Olcott A; Kaufman DL
    J Immunol; 2001 Jul; 167(2):1081-9. PubMed ID: 11441119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of nonobese diabetic mouse T-cells that recognize novel autoantigens involved in the early events of diabetes.
    Gelber C; Paborsky L; Singer S; McAteer D; Tisch R; Jolicoeur C; Buelow R; McDevitt H; Fathman CG
    Diabetes; 1994 Jan; 43(1):33-9. PubMed ID: 8262314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice.
    Falcone M; Lee J; Patstone G; Yeung B; Sarvetnick N
    J Immunol; 1998 Aug; 161(3):1163-8. PubMed ID: 9686575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.